Annual EBITDA
$9.11B$410.22M+4.71%
Summary
- Current Value
- As of today, TAK annual EBITDA is $9.11B, up +4.71% on
- Historical Performance
- TAK annual EBITDA is down -14.23% over the past 3 years, and up +11.77% over the past 5 years
- All-Time High Comparison
- TAK annual EBITDA is currently -14.23% below its historical high of $10.62B set on
- 3-Year Low Comparison
- TAK annual EBITDA is +4.71% above its 3-year low of $8.70B reached on
- Sector Comparison
- TAK annual EBITDA is higher than 99.06% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $9.11B | +4.7% | -14.2% | +11.8% | +58.1% | |
| Quarterly EBITDA | $2.47B | +11.4% | -3.9% | -8.8% | +48.9% | |
| TTM EBITDA | $8.65B | -4.8% | -5.6% | -10.4% | +49.8% | |
| Price | $17.74 | +32.7% | +11.1% | +3.3% | -27.3% | |
| PE Ratio | 73.67 | +134.2% | +195.2% | +132.6% | +463.2% | |
| Annual Revenue | $30.05B | +1.9% | -5.4% | -0.7% | +90.4% | |
| Annual EPS | $0.22 | -30.0% | -66.0% | +69.8% | -89.1% | |
| $4.12B | +12.3% | -24.2% | +47.9% | -9.0% | ||
| Annual Net Income | $709.37M | -28.9% | -65.4% | +74.1% | -78.0% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $10.62B | N/A | -14.2% |
| 5Y | $10.62B | -14.2% | |
| All | $10.62B | -14.2% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $8.70B | +4.7% | |
| 5Y | $8.15B | N/A | +11.8% |
| All | $572.38M | +1491.7% |
EBITDA History
FAQ
What is the current annual EBITDA of TAK?
As of today, TAK annual EBITDA is $9.11B
What is 1-year change in TAK annual EBITDA?
TAK annual EBITDA is up +4.71% year-over-year
What is 3-year change in TAK annual EBITDA?
TAK annual EBITDA is down -14.23% over the past 3 years
How far is TAK annual EBITDA from its all-time high?
TAK annual EBITDA is currently -14.23% below its historical high of $10.62B set on March 31, 2022
How does TAK annual EBITDA rank versus sector peers?
TAK annual EBITDA is higher than 99.06% of companies in Healthcare sector
When is TAK next annual earnings release?
The next annual earnings release for TAK is on
Quarterly EBITDA
$2.47B$319.60M+14.83%
Summary
- Current Value
- As of today, TAK quarterly EBITDA is $2.47B, up +14.83% on
- Historical Performance
- TAK quarterly EBITDA is up +11.39% year-over-year, and down -3.85% over the past 3 years
- All-Time High Comparison
- TAK quarterly EBITDA is currently -33.34% below its historical high of $3.71B set on
- 3-Year Low Comparison
- TAK quarterly EBITDA is +71.24% above its 3-year low of $1.45B reached on
- Sector Comparison
- TAK quarterly EBITDA is higher than 98.72% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $2.47B | +14.8% | +11.4% | -3.9% | -8.8% | |
| Annual EBITDA | $9.11B | – | +4.7% | -14.2% | +11.8% | |
| TTM EBITDA | $8.65B | +3.0% | -4.8% | -5.6% | -10.4% | |
| Price | $17.74 | +30.5% | +32.7% | +11.1% | +3.3% | |
| PE Ratio | 73.67 | -57.3% | +134.2% | +195.2% | +132.6% | |
| Quarterly Revenue | $7.73B | +2.5% | +3.0% | -0.3% | -3.4% | |
| Quarterly EPS | $0.21 | +929.6% | +339.1% | -21.7% | -25.1% | |
| $1.24B | +62.1% | +24.4% | -6.5% | -10.2% | ||
| Quarterly Net Income | $673.28M | +946.3% | +330.4% | -20.1% | -23.9% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $2.57B | -3.9% | |
| 3Y | $2.68B | -7.7% | |
| 5Y | $3.71B | -33.3% | |
| All | $3.71B | -33.3% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $1.45B | +71.2% | |
| 3Y | $1.45B | +71.2% | |
| 5Y | $1.45B | +71.2% | |
| All | -$1.91B | +229.5% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of TAK?
As of today, TAK quarterly EBITDA is $2.47B
What is TAK quarterly EBITDA most recent change?
TAK quarterly EBITDA was up +14.83% on December 31, 2025
What is 1-year change in TAK quarterly EBITDA?
TAK quarterly EBITDA is up +11.39% year-over-year
How far is TAK quarterly EBITDA from its all-time high?
TAK quarterly EBITDA is currently -33.34% below its historical high of $3.71B set on June 30, 2021
How does TAK quarterly EBITDA rank versus sector peers?
TAK quarterly EBITDA is higher than 98.72% of companies in Healthcare sector
When is TAK next earnings release?
The next earnings release for TAK is on
TTM EBITDA
$8.65B$253.11M+3.01%
Summary
- Current Value
- As of today, TAK TTM EBITDA is $8.65B, up +3.01% on
- Historical Performance
- TAK TTM EBITDA is down -4.76% year-over-year, and down -5.60% over the past 3 years
- All-Time High Comparison
- TAK TTM EBITDA is currently -18.68% below its historical high of $10.64B set on
- 3-Year Low Comparison
- TAK TTM EBITDA is +4.19% above its 3-year low of $8.30B reached on
- Sector Comparison
- TAK TTM EBITDA is higher than 98.63% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $8.65B | +3.0% | -4.8% | -5.6% | -10.4% | |
| Annual EBITDA | $9.11B | – | +4.7% | -14.2% | +11.8% | |
| Quarterly EBITDA | $2.47B | +14.8% | +11.4% | -3.9% | -8.8% | |
| Price | $17.74 | +30.5% | +32.7% | +11.1% | +3.3% | |
| PE Ratio | 73.67 | -57.3% | +134.2% | +195.2% | +132.6% | |
| TTM Revenue | $29.85B | +0.8% | -1.2% | -0.5% | -0.4% | |
| TTM EPS | $0.24 | +206.0% | -43.4% | -62.4% | -55.6% | |
| $3.52B | +7.4% | -13.6% | -15.6% | -19.3% | ||
| TTM Net Income | $776.90M | +198.8% | -43.1% | -61.1% | -54.4% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $9.08B | N/A | -4.8% |
| 3Y | $9.52B | -9.1% | |
| 5Y | $10.64B | -18.7% | |
| All | $10.64B | -18.7% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $8.40B | +3.0% | |
| 3Y | $8.30B | +4.2% | |
| 5Y | $8.30B | +4.2% | |
| All | -$38.80M | >+9999.0% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of TAK?
As of today, TAK TTM EBITDA is $8.65B
What is TAK TTM EBITDA most recent change?
TAK TTM EBITDA was up +3.01% on December 31, 2025
What is 1-year change in TAK TTM EBITDA?
TAK TTM EBITDA is down -4.76% year-over-year
How far is TAK TTM EBITDA from its all-time high?
TAK TTM EBITDA is currently -18.68% below its historical high of $10.64B set on September 30, 2021
How does TAK TTM EBITDA rank versus sector peers?
TAK TTM EBITDA is higher than 98.63% of companies in Healthcare sector
When is TAK next earnings release?
The next earnings release for TAK is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- TAK Official Website www.takeda.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1395064/000139506426000002/0001395064-26-000002-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1395064/000139506425000095/0001395064-25-000095-index.htm
- TAK Profile on Yahoo Finance finance.yahoo.com/quote/TAK
- TAK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/tak